Author response to Colle et al

by Fucà, Giovanni, Corti, Francesca, Pietrantonio, Filippo
Published in J Immunother Cancer (2021)

Continuing Single-Agent Bevacizumab as Maintenance Therapy After Induction XELOX (or FOLFOX) Plus Bevacizumab in First-Line Treatment of Metastatic Colorectal Cancer

by Díaz-Rubio, Eduardo, Pietrantonio, Filippo, de Braud, Filippo
Published 2012

LightSNiP assay is a good strategy for pharmacogenetics test

by Cheli, Stefania, Pietrantonio, Filippo, Clementi, Emilio, Falvella, Felicia S.
Published in Front Pharmacol (2015)

Adjuvant chemotherapy for gastric cancer: Current evidence and future challenges

by Miceli, Rosalba, Tomasello, Gianluca, Bregni, Giacomo, Di Bartolomeo, Maria, Pietrantonio, Filippo
Published 2014

BRAF-mutated metastatic colorectal cancer between past and future

by Cremolini, Chiara, Di Maio, Massimo, Petrelli, Fausto, Berenato, Rosa, Loupakis, Fotios, Pietrantonio, Filippo
Published in Br J Cancer (2015)

Targeting cancer metabolism: dietary and pharmacological interventions

by Vernieri, Claudio, Casola, Stefano, Foiani, Marco, Pietrantonio, Filippo, de Braud, Filippo, Longo, Valter
Published in Cancer Discov (2016)

Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5- fluorouracil: a meta-analysis of published trials

by Iacovelli, Roberto, Pietrantonio, Filippo, Palazzo, Antonella, Maggi, Claudia, Ricchini, Francesca, de Braud, Filippo, Di Bartolomeo, Maria
Published in Br J Clin Pharmacol (2014)

Bevacizumab treatment in the elderly patient with metastatic colorectal cancer

by Di Bartolomeo, Maria, Maggi, Claudia, Ricchini, Francesca, Pietrantonio, Filippo, Iacovelli, Roberto, de Braud, Filippo, Inno, Alessandro
Published in Clin Interv Aging (2015)

In Reply

by Baratti, Dario, Kusamura, Shigeki, Maggi, Claudia, de Braud, Filippo, Deraco, Marcello, Di Bartolomeo, Maria, Pietrantonio, Filippo
Published in Oncologist (2015)

Bax Expression Is Predictive of Favorable Clinical Outcome in Chemonaive Advanced Gastric Cancer Patients Treated with Capecitabine, Oxaliplatin, and Irinotecan Regimen

by Pietrantonio, Filippo, Biondani, Pamela, de Braud, Filippo, Pellegrinelli, Alessandro, Bianchini, Giampaolo, Perrone, Federica, Formisano, Barbara, Di Bartolomeo, Maria
Published 2012

Chemotherapy or Targeted Therapy as Second-Line Treatment of Advanced Gastric Cancer. A Systematic Review and Meta-Analysis of Published Studies

by Iacovelli, Roberto, Pietrantonio, Filippo, Farcomeni, Alessio, Maggi, Claudia, Palazzo, Antonella, Ricchini, Francesca, de Braud, Filippo, Di Bartolomeo, Maria
Published 2014

Panitumumab‐based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials

by Modest, Dominik Paul, Rivera, Fernando, Bachet, Jean‐Baptiste, de Braud, Filippo, Pietrantonio, Filippo, Koukakis, Reija, Demonty, Gaston, Douillard, Jean‐Yves
Published in Int J Cancer (2019)

The Landscape of Actionable Gene Fusions in Colorectal Cancer

by Pagani, Filippo, Randon, Giovanni, Guarini, Vincenzo, Raimondi, Alessandra, Prisciandaro, Michele, Lobefaro, Riccardo, Di Bartolomeo, Maria, Sozzi, Gabriella, de Braud, Filippo, Gasparini, Patrizia, Pietrantonio, Filippo
Published in Int J Mol Sci (2019)

Role of MGMT as biomarker in colorectal cancer

by Inno, Alessandro, Fanetti, Giuseppe, Di Bartolomeo, Maria, Gori, Stefania, Maggi, Claudia, Cirillo, Massimo, Iacovelli, Roberto, Nichetti, Federico, Martinetti, Antonia, de Braud, Filippo, Bossi, Ilaria, Pietrantonio, Filippo
Published in World J Clin Cases (2014)

Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Med...

by Dieci, Maria Vittoria, Massari, Francesco, Giusti, Raffaele, Inno, Alessandro, Lombardi, Giuseppe, Noto, Laura, Passaro, Antonio, Pietrantonio, Filippo, Spada, Francesca, Valente, Monica, Di Maio, Massimo, Torri, Valter
Published in ESMO Open (2018)

Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens

by Martinetti, Antonia, Miceli, Rosalba, Sottotetti, Elisa, Di Bartolomeo, Maria, de Braud, Filippo, Gevorgyan, Arpine, Dotti, Katia Fiorella, Bajetta, Emilio, Campiglio, Manuela, Bianchi, Francesca, Bregni, Giacomo, Pietrantonio, Filippo
Published 2014

miR‐205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling

by Migliore, Cristina, Morando, Elena, Ghiso, Elena, Anastasi, Sergio, Leoni, Vera P, Apicella, Maria, Cora', Davide, Sapino, Anna, Pietrantonio, Filippo, De Braud, Filippo, Columbano, Amedeo, Segatto, Oreste, Giordano, Silvia
Published in EMBO Mol Med (2018)

Practical considerations in the use of regorafenib in metastatic colorectal cancer

by Loupakis, Fotios, Antonuzzo, Lorenzo, Bachet, Jean-Baptiste, Kuan, Feng-Che, Macarulla, Teresa, Pietrantonio, Filippo, Xu, Rui-Hua, Taniguchi, Hiroya, Winder, Thomas, Yuki, Satoshi, Zeng, Shan, Bekaii-Saab, Tanios
Published in Ther Adv Med Oncol (2020)

Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status

by Pietrantonio, Filippo, Maggi, Claudia, Di Bartolomeo, Maria, Facciorusso, Maria Grazia, Perrone, Federica, Testi, Adele, Iacovelli, Roberto, Miceli, Rosalba, Bossi, Ilaria, Leone, Giorgia, Milione, Massimo, Pelosi, Giuseppe, de Braud, Filippo
Published 2014

Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis

by Petrelli, Fausto, Berenato, Rosa, Turati, Luca, Mennitto, Alessia, Steccanella, Francesca, Caporale, Marta, Dallera, Pierpaolo, de Braud, Filippo, Pezzica, Ezio, Di Bartolomeo, Maria, Sgroi, Giovanni, Mazzaferro, Vincenzo, Pietrantonio, Filippo, Barni, Sandro
Published in J Gastrointest Oncol (2017)